生物活性 靶点 体外研究 体内研究 AT-56 试剂级价格
ChemicalBook  CAS数据库列表  AT-56

AT-56

AT-56,162640-98-4,结构式
AT-56
  • CAS号:162640-98-4
  • 英文名:AT-56
  • 中文名:AT-56
  • CBNumber:CB72518821
  • 分子式:C25H27N5
  • 分子量:397.52
  • MOL File:162640-98-4.mol
AT-56化学性质
  • 沸点 :620.4±65.0 °C(Predicted)
  • 密度 :1.216±0.06 g/cm3(Predicted)
  • 储存条件 :Inert atmosphere,Store in freezer, under -20°C
  • 溶解度 :DMSO: soluble10mg/mL, clear
  • 酸度系数(pKa) :4.99±0.10(Predicted)
  • 形态 :powder
  • 颜色 :white to beige
  • InChIKey :LQNGMDUIRLSESZ-UHFFFAOYSA-N
  • SMILES :N1(CCCCC2=NNN=N2)CC/C(=C2/C3=CC=CC=C3C=CC3=CC=CC=C3/2)/CC1
安全信息
  • WGK Germany :3

AT-56性质、用途与生产工艺

  • 生物活性 AT-56 是一种口服活性的 lipocalin-type prostaglandin (PG) D synthase (L-PGDS) 的选择性抑制剂,对应的Ki值和IC50值分别为75 μM和95 μM。
  • 靶点
    TargetValue
    L-PGDS
    (Cell-free assay)
    75 μM(Ki)
    L-PGDS
    (Cell-free assay)
    95 μM
  • 体外研究

    AT-56 (1-30 μM; 10 minutes) dose-dependently inhibits the production of PGD 2 in L-PGDS-expressing human medulloblastoma TE-671 cells with an IC 50 of about 3 μM.

  • 体内研究

    AT-56 ( 1-30 mg/kg; p.o.) suppresses the PGD 2 production in the stab-wounded brain.
    AT-56 (1-10 mg/kg; p.o.) suppresses the L-PGDS-mediated allergic airway inflammation in mice.
    AT-56 (10 mg/kg; p.o.) exhibits C max (2.15 μg/ml), half-life (1.71 h) and high oral bioavailability (82%).

    Animal Model: H-PGDS KO mice (14-16weeks, 25-30 g, C57BL/6 strain) with a stab wound brain injury
    Dosage: 0, 1, 3, 10, 30 mg/kg
    Administration: P.o. 1 h before the stab wound injury
    Result: Inhibited the L-PGDS reaction in the brain.
    Decreased the total amount of PGD 2 in the brain to 40% with 30 mg/kg AT-56.
    Animal Model: Human L-PGDS-overexpressing TG mice (males, 14-16 weeks, 25-30 g)
    Dosage: 0, 1, 10 mg/kg
    Administration: P.o. 1 h before and 24 h after the antigen exposure
    Result: Prevented the eosinophil infiltration by inhibiting transgened human L-PGDS.
    Animal Model: Male C57BL/6 mice (7 weeks, 22-26 g)
    Dosage: 10 mg/kg for p.o. and 2 mg/kg for i.v. (Pharmacokinetic Analysis)
    Administration: P.o. and i.v. administration
    Result: Oral bioavailability (82%); C max (2.15 μg/ml); T 1/2 (1.71 h, p.o.); T 1/2 (2.35 h, i.v.).
AT-56上下游产品信息
上游原料
下游产品
AT-56 试剂级价格
  • 更新日期:2024/11/08
  • 产品编号:HY-13988
  • 产品名称:AT-56
  • CAS编号:
  • 包装:1 mg
  • 价格:380元
  • 更新日期:2024/11/08
  • 产品编号:HY-13988
  • 产品名称:AT-56 AT-56
  • CAS编号:162640-98-4
  • 包装:5mg
  • 价格:950元
AT-56生产厂家
  • 公司名称:TORONTO
  • 联系电话:--
  • 电子邮件:info@trc-canada.com
  • 国家:加拿大
  • 产品数:6038
  • 优势度:71